Clinical Trial

Demyelinating Diseases of the Central Nervous System Registry for Patients With Traditional Chinese Medicine (DATE-TCM)

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Demyelinating Diseases of the Central Nervous System Registry for Patients with Traditional Chinese Medicine (DATE-TCM) is an observational study aiming to better define the multidimensional (epidemiologic, demographic and clinical) characteristics of Demyelinating Diseases of the Central Nervous System (DDC) patients receiving Traditional Chinese medicine (TCM) treatment, the type and long-term safety and effectiveness of TCM in DDC populations, as well as the interaction of TCM treatment and disease-modifying therapy in the management of DDC.
Trial Details
NCT Number NCT05415579
Lead Sponsor Dongzhimen Hospital, Beijing
Conditions Demyelinating Diseases of the Central Nervous System (DDC)
Enrollment 2,000 participants
Start Date 2022-06-20
Primary Completion 2029-10-31 (estimated)
Study Completion 2030-05-31 (estimated)
Updated on ClinicalTrials.gov 2022-06-13